Dr Arek Hidirsah, MD | |
620 John Paul Jones Cir Dept Aya, Portsmouth, VA 23708-2111 | |
(757) 953-0167 | |
(757) 953-0058 |
Full Name | Dr Arek Hidirsah |
---|---|
Gender | Male |
Speciality | Pediatrics - Adolescent Medicine |
Location | 620 John Paul Jones Cir Dept Aya, Portsmouth, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093177073 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080A0000X | Pediatrics - Adolescent Medicine | A162777 (California) | Secondary |
2080A0000X | Pediatrics - Adolescent Medicine | 0101263112 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Arek Hidirsah, MD 620 John Paul Jones Cir Dept Aya, Portsmouth, VA 23708-2111 Ph: (757) 953-0167 | Dr Arek Hidirsah, MD 620 John Paul Jones Cir Dept Aya, Portsmouth, VA 23708-2111 Ph: (757) 953-0167 |
News Archive
Awarepoint Corporation, the leading provider of real-time location systems (RTLS) for hospitals, today announced that the U.S. Patent and Trademark Office has awarded the company Patent No. 7,941,096 for a wireless interaction-based tracking system that helps hospitals enhance their patient safety, improve quality of care, and drive better financial outcomes.
A new study led by Amitai Abramovitch, assistant professor in the Department of Psychology at Texas State University, shows that individuals with obsessive-compulsive disorder (OCD) are significantly less likely to become overweight or obese.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B/2 dose-ranging clinical study with its anticoagulant reversing agent, PMX-60056. The study is intended to demonstrate the safety and efficacy of PMX-60056 in reversing varying heparin levels, including the highest levels commonly used in surgical settings.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
› Verified 5 days ago
Justin Hollon, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Circle, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-4529 Fax: 757-953-3293 | |
Dr. Mary Elizabeth Watson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Naval Medical Center Portsmouth, Dept. Of Pediatrics, Portsmouth, VA 23708 Phone: 757-953-2960 | |
Dr. Clinton Forrest Faison Iii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Circle, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-7424 Fax: 757-953-5104 | |
Dr. Rebecca D. Christi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5652 | |
Dr. Shawn Jamison Miller, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-2958 | |
Dr. John Kenyon Watson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-2983 Fax: 757-953-0858 |